Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2020 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2020 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model

  • Authors:
    • Hai‑Lian Du
    • Ai‑Dong Zhai
    • Hong Yu
  • View Affiliations / Copyright

    Affiliations: Department of Respiratory Medicine, Yidu Central Hospital Affiliated to Weifang Medical College, Qingzhou, Shandong 262500, P.R. China, Department of Internal Medicine, Maternal and Child Health Hospital of Zibo, Zibo, Shandong 255029, P.R. China, Intensive Care Unit, Second Hospital of Harbin City, Harbin, Heilongjiang 150036, P.R. China
  • Pages: 927-935
    |
    Published online on: December 6, 2019
       https://doi.org/10.3892/mmr.2019.10865
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute lung injury (ALI) is characterized by neutrophilic infiltration, uncontrolled oxidative stress and inflammatory processes. Despite various therapeutic regimes having been performed, there remains no effective pharmacotherapy available to treat ALI. Halofuginone (HF), a ketone isolated from Dichroa febrifuga, exhibits significant anti‑inflammatory and antifibrotic effects. Dexamethasone (DEX), a synthetic glucocorticoid, has been routinely used as an adjuvant therapy in treating inflammatory diseases, including ALI. The present study aimed to investigate the effects of the combination of HF and DEX in the treatment of ALI. The present results suggested that the simultaneous administration of HF and DEX markedly decreased the level of pro‑inflammatory cytokines and increased the level of anti‑inflammatory cytokines, as assessed by western blot analysis. In addition, HF and DEX effectively decreased nuclear factor‑κB activity via suppressing the phosphorylation of P65 in lipopolysaccharide (LPS)‑induced human pulmonary alveolar epithelial cells (HPAEpiC) and lung tissues extracted from ALI rats, as determined by immunofluorescence. Furthermore, in vivo experiments demonstrated that the combination of HF and DEX in LPS‑induced ALI rats defended against lung fibrosis, perivascular inflammation, congestion and edema of pulmonary alveoli, as assessed by histopathological analysis, TUNEL staining and immunohistochemistry assay. Taken together, the present study indicated the synergistic effect of HF and DEX on LPS‑induced ALI in HPAEpiC cells and a rat model. These results offer a novel therapeutic approach for the treatment of ALI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Miyashita T, Ahmed AK, Nakanuma S, Okamoto K, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, et al: A three-phase approach for the early identification of acute lung injury induced by severe sepsis. In Vivo. 30:341–349. 2016.PubMed/NCBI

2 

Zimmerman JJ, Akhtar SR, Caldwell E and Rubenfeld GD: Incidence and outcomes of pediatric acute lung injury. Pediatrics. 124:87–95. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Sawa T: The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: From bacterial pathogenesis to host response. J Intensive Care. 2:102014. View Article : Google Scholar : PubMed/NCBI

4 

Hu Y, Ren J, Wang L, Zhao X, Zhang M, Shimizu K and Zhang C: Protective effects of total alkaloids from Dendrobium crepidatum against LPS-induced acute lung injury in mice and its chemical components. Phytochemistry. 149:12–23. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Patel VJ, Biswas Roy S, Mehta HJ, Joo M and Sadikot RT: Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome. Biomed Res Int. 2018:24768242018. View Article : Google Scholar : PubMed/NCBI

6 

Johnson ER and Matthay MA: Acute lung injury: Epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv. 23:243–252. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S and Schmidt-Ullrich R: Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res. 159:283–300. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Pines M, Snyder D, Yarkoni S and Nagler A: Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant. 9:417–425. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Park MK, Park JS, Park EM, Lim MA, Kim SM, Lee DG, Baek SY, Yang EJ, Woo JW, Lee J, et al: Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. Arthritis Rheumatol. 66:1195–1207. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Zeng S, Wang K, Huang M, Qiu Q, Xiao Y, Shi M, Zou Y, Yang X, Xu H and Liang L: Halofuginone inhibits TNF-α-induced the migration and proliferation of fibroblast-like synoviocytes from rheumatoid arthritis patients. Int Immunopharmacol. 43:187–194. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Oishi H, Martinu T, Sato M, Matsuda Y, Hirayama S, Juvet SC, Guan Z, Saito T, Cypel M, Hwang DM, et al: Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model. J Heart Lung Transplant. 35:518–527. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Gao W, Tong D, Li Q, Huang P and Zhang F: Dexamethasone promotes regeneration of crushed inferior alveolar nerve by inhibiting NF-κB activation in adult rats. Arch Oral Biol. 80:101–109. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Wang A, Wang F, Yin Y, Zhang M and Chen P: Dexamethasone reduces serum level of IL-17 in Bleomycin-A5-induced rats model of pulmonary fibrosis. Artif Cells Nanomed Biotechnol. 46:783–787. 2018. View Article : Google Scholar : PubMed/NCBI

14 

Roach BL, Kelmendi-Doko A, Balutis EC, Marra KG, Ateshian GA and Hung CT: Dexamethasone release from within engineered cartilage as a chondroprotective strategy against interleukin-1α. Tissue Eng Part A. 22:621–632. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Palma L, Sfara C, Antonelli A and Magnani M: Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages. BMC Pharmacol. 11:82011. View Article : Google Scholar : PubMed/NCBI

16 

Wang Q, Jiang H, Li Y, Chen W, Li H, Peng K, Zhang Z and Sun X: Targeting NF-κB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 122:10–22. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Shaughnessy AF: Single-dose dexamethasone an option for acute adult asthma. Am Fam Physician. 95:Online2017.

18 

Kosutova P, Mikolka P, Balentova S, Adamkov M, Kolomaznik M, Calkovska A and Mokra D: Intravenous dexamethasone attenuated inflammation and influenced apoptosis of lung cells in an experimental model of acute lung injury. Physiol Res. 65 (Suppl 5):S663–S672. 2016.PubMed/NCBI

19 

Liu F, Pauluhn J, Trubel H and Wang C: Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats. Toxicology. 315:17–23. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Zhang S, Chen X, Devshilt I, Yun Q, Huang C, An L, Dorjbat S and He X: Fennel main constituent, trans-anethole treatment against LPS-induced acute lung injury by regulation of Th17/Treg function. Mol Med Rep. 18:1369–1376. 2018.PubMed/NCBI

21 

Park GY and Christman JW: Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets. 7:661–668. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Ho YC, Lee SS, Yang ML, Huang-Liu R, Lee CY, Li YC and Kuan YH: Zerumbone reduced the inflammatory response of acute lung injury in endotoxin-treated mice via Akt-NFκB pathway. Chem Biol Interact. 271:9–14. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Wang T, Hou W and Fu Z: Preventative effect of OMZ-SPT on lipopolysaccharide-induced acute lung injury and inflammation via nuclear factor-kappa B signaling in mice. Biochem Biophys Res Commun. 485:284–289. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Li N, Song Y, Zhao W, Han T, Lin S, Ramirez O and Liang L: Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats. BMC Physiol. 16:72016. View Article : Google Scholar : PubMed/NCBI

25 

Li Q, Gu Y, Tu Q, Wang K, Gu X and Ren T: Blockade of Interleukin-17 restrains the development of acute lung injury. Scand J Immunol. 83:203–211. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Yan B, Chen F, Xu L, Xing J and Wang X: HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice. Sci Rep. 7:5972017. View Article : Google Scholar : PubMed/NCBI

27 

D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, Pipeling MR, Brower RG, Tuder RM, McDyer JF and King LS: CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 119:2898–2913. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Liu TY and Chen SB: Sarcandra glabra combined with lycopene protect rats from lipopolysaccharide induced acute lung injury via reducing inflammatory response. Biomed Pharmacother. 84:34–41. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Wei CY, Sun HL, Yang ML, Yang CP, Chen LY, Li YC, Lee CY and Kuan YH: Protective effect of wogonin on endotoxin-induced acute lung injury via reduction of p38 MAPK and JNK phosphorylation. Environ Toxicol. 32:397–403. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Kao ST, Liu CJ and Yeh CC: Protective and immunomodulatory effect of flos Lonicerae japonicae by augmenting IL-10 expression in a murine model of acute lung inflammation. J Ethnopharmacol. 168:108–115. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Wang X, Zhang L, Duan W, Liu B, Gong P, Ding Y and Wu X: Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. Mol Med Rep. 10:447–452. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Liu J, Xiao HT, Wang HS, Mu HX, Zhao L, Du J, Yang D, Wang D, Bian ZX and Lin SH: Halofuginone reduces the inflammatory responses of DSS-induced colitis through metabolic reprogramming. Mol Biosyst. 12:2296–2303. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Sun XH, Fu J and Sun DQ: Halofuginone alleviates acute viral myocarditis in suckling BALB/c mice by inhibiting TGF-β1. Biochem Biophys Res Commun. 473:558–564. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R and Serpe L: Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol. 23:4200–4210. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Leguillette R, Tohver T, Bond SL, Nicol JA and McDonald KJ: Effect of dexamethasone and fluticasone on airway hyperresponsiveness in horses with inflammatory airway disease. J Vet Intern Med. 31:1193–1201. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Soiberman U, Kambhampati SP, Wu T, Mishra MK, Oh Y, Sharma R, Wang J, Al Towerki AE, Yiu S, Stark WJ and Kannan RM: Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation. Biomaterials. 125:38–53. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Kozan A, Kilic N, Alacam H, Guzel A, Guvenc T and Acikgoz M: The effects of dexamethasone and L-NAME on acute lung injury in rats with lung contusion. Inflammation. 39:1747–1756. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Liang J, Zhang B, Shen RW, Liu JB, Gao MH, Li Y, Li YY and Zhang W: Preventive effect of halofuginone on concanavalin A-induced liver fibrosis. PLoS One. 8:e822322013. View Article : Google Scholar : PubMed/NCBI

39 

Carlson TJ, Pellerin A, Djuretic IM, Trivigno C, Koralov SB, Rao A and Sundrud MS: Halofuginone-induced amino acid starvation regulates Stat3-dependent Th17 effector function and reduces established autoimmune inflammation. J Immunol. 192:2167–2176. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Kotthoff P, Heine A, Held SAE and Brossart P: Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways. Sci Rep. 7:45222017. View Article : Google Scholar : PubMed/NCBI

41 

Yeh YC, Yang CP, Lee SS, Horng CT, Chen HY, Cho TH, Yang ML, Lee CY, Li MC and Kuan YH: Acute lung injury induced by lipopolysaccharide is inhibited by wogonin in mice via reduction of Akt phosphorylation and RhoA activation. J Pharm Pharmacol. 68:257–263. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Lu X, Pu Y, Kong W, Tang X, Zhou J, Gou H, Song X, Zhou H, Gao N and Shen J: Antidesmone, a unique tetrahydroquinoline alkaloid, prevents acute lung injury via regulating MAPK and NF-κB activities. Int Immunopharmacol. 45:34–42. 2017. View Article : Google Scholar : PubMed/NCBI

43 

He J, Zhou J, Yang W, Zhou Q, Liang X, Pang X, Li J, Pan F and Liang H: Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB. Oncotarget. 8:67670–67683. 2017.PubMed/NCBI

44 

Xu J, Liu D, Yin Q and Guo L: Tetrandrine suppresses β-glucan-induced macrophage activation via inhibiting NF-κB, ERK and STAT3 signaling pathways. Mol Med Rep. 13:5177–5184. 2016. View Article : Google Scholar : PubMed/NCBI

45 

Huang CS, Lin AH, Yang TC, Liu KL, Chen HW and Lii CK: Shikonin inhibits oxidized LDL-induced monocyte adhesion by suppressing NFκB activation via up-regulation of PI3K/Akt/Nrf2-dependent antioxidation in EA.hy926 endothelial cells. Biochem Pharmacol. 93:352–361. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Li K, He Z, Wang X, Pineda M, Chen R, Liu H, Ma K, Shen H, Wu C, Huang N, et al: Apigenin C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway. Free Radic Biol Med. 124:163–175. 2018. View Article : Google Scholar : PubMed/NCBI

47 

Qing R, Huang Z, Tang Y, Xiang Q and Yang F: Cordycepin alleviates lipopolysaccharide-induced acute lung injury via Nrf2/HO-1 pathway. Int Immunopharmacol. 60:18–25. 2018. View Article : Google Scholar : PubMed/NCBI

48 

Chen LJ, Ding YB, Ma PL, Jiang SH, Li KZ, Li AZ, Li MC, Shi CX, Du J and Zhou HD: The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-κB and p38 MAPK signaling pathway and excessive inflammatory responses. Eur Rev Med Pharmacol Sci. 22:2099–2108. 2018.PubMed/NCBI

49 

Yavas G, Calik M, Calik G, Yavas C, Ata O and Esme H: The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis. Med Hypotheses. 80:357–359. 2013. View Article : Google Scholar : PubMed/NCBI

50 

Nagler A, Firman N, Feferman R, Cotev S, Pines M and Shoshan S: Reduction in pulmonary fibrosis in vivo by halofuginone. Am J Respir Crit Care Med. 154:1082–1086. 1996. View Article : Google Scholar : PubMed/NCBI

51 

Wigenstam E, Elfsmark L, Ågren L, Akfur C, Bucht A and Jonasson S: Anti-inflammatory and anti-fibrotic treatment in a rodent model of acute lung injury induced by sulfur dioxide. Clin Toxicol (Phila). 56:1185–1194. 2018. View Article : Google Scholar : PubMed/NCBI

52 

Xu X, Zhu Q, Niu F, Zhang R, Wang Y, Wang W, Sun D, Wang X and Wang A: A2BAR activation attenuates acute lung injury by inhibiting alveolar epithelial cell apoptosis both in vivo and in vitro. Am J Physiol Cell Physiol. 315:C558–C570. 2018. View Article : Google Scholar : PubMed/NCBI

53 

Ehrentraut H, Weisheit C, Scheck M, Frede S and Hilbert T: Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages. J Inflamm (Lond). 15:122018. View Article : Google Scholar : PubMed/NCBI

54 

Dong SA, Zhang Y, Yu JB, Li XY, Gong LR, Shi J and Kang YY: Carbon monoxide attenuates lipopolysaccharide-induced lung injury by mitofusin proteins via p38 MAPK pathway. J Surg Res. 228:201–210. 2018. View Article : Google Scholar : PubMed/NCBI

55 

Takaoka Y, Goto S, Nakano T, Tseng HP, Yang SM, Kawamoto S, Ono K and Chen CL: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep. 4:52042014. View Article : Google Scholar : PubMed/NCBI

56 

Yang Q, Liu X, Yao Z, Mao S, Wei Q and Chang Y: Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice. J Surg Res. 186:310–317. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Du HL, Zhai AD and Yu H: Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model. Mol Med Rep 21: 927-935, 2020.
APA
Du, H., Zhai, A., & Yu, H. (2020). Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model. Molecular Medicine Reports, 21, 927-935. https://doi.org/10.3892/mmr.2019.10865
MLA
Du, H., Zhai, A., Yu, H."Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model". Molecular Medicine Reports 21.2 (2020): 927-935.
Chicago
Du, H., Zhai, A., Yu, H."Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model". Molecular Medicine Reports 21, no. 2 (2020): 927-935. https://doi.org/10.3892/mmr.2019.10865
Copy and paste a formatted citation
x
Spandidos Publications style
Du HL, Zhai AD and Yu H: Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model. Mol Med Rep 21: 927-935, 2020.
APA
Du, H., Zhai, A., & Yu, H. (2020). Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model. Molecular Medicine Reports, 21, 927-935. https://doi.org/10.3892/mmr.2019.10865
MLA
Du, H., Zhai, A., Yu, H."Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model". Molecular Medicine Reports 21.2 (2020): 927-935.
Chicago
Du, H., Zhai, A., Yu, H."Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model". Molecular Medicine Reports 21, no. 2 (2020): 927-935. https://doi.org/10.3892/mmr.2019.10865
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team